Effects of aging on B cell function

Current Opinion in Immunology

Volumn 21, Issue 4, 2009, Pages 425-430

  Frasca, Daniela ^a   Blomberg, Bonnie B ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE DEAMINASE; IMMUNOGLOBULIN CLASS; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E47; UNCLASSIFIED DRUG;

AGING; ANTIBODY RESPONSE; B LYMPHOCYTE; DRUG RESPONSE; ELDERLY CARE; FLOW CYTOMETRY; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOPATHOLOGY; LYMPHOCYTE FUNCTION; MICROARRAY ANALYSIS; MOLECULAR BIOLOGY; NONHUMAN; REVIEW; SOMATIC HYPERMUTATION;

AGING; ANIMALS; B-LYMPHOCYTES; CYTIDINE DEAMINASE; GENE EXPRESSION REGULATION; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULIN CLASS SWITCHING; MICE; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN; TCF TRANSCRIPTION FACTORS;

EID: 68149124429     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2009.06.001     Document Type: Review

References (56)

1. Klein U., and Dalla-Favera R. Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol 8 (2008) 22-33
2. Cerutti A. The regulation of IgA class switching. Nat Rev Immunol 8 (2008) 421-434
3. Garcia de Vinuesa C., O'Leary P., Sze D.M., Toellner K.M., and MacLennan I.C. T-independent type 2 antigens induce B cell proliferation in multiple splenic sites, but exponential growth is confined to extrafollicular foci. Eur J Immunol 29 (1999) 1314-1323
4. McHeyzer-Williams M.G. B cells as effectors. Curr Opin Immunol 15 (2003) 354-361
5. Tarlinton D., Radbruch A., Hiepe F., and Dorner T. Plasma cell differentiation and survival. Curr Opin Immunol 20 (2008) 162-169
6. Zheng B., Han S., Takahashi Y., and Kelsoe G. Immunosenescence and germinal center reaction. Immunol Rev 160 (1997) 63-77
7. Eaton S.M., Burns E.M., Kusser K., Randall T.D., and Haynes L. Age-related defects in CD4 T cell cognate helper function lead to reductions in humoral responses. J Exp Med 200 (2004) 1613-1622
8. Manz R.A., Thiel A., and Radbruch A. Lifetime of plasma cells in the bone marrow. Nature 388 (1997) 133-134
9. Han S., Yang K., Ozen Z., Peng W., Marinova E., Kelsoe G., and Zheng B. Enhanced differentiation of splenic plasma cells but diminished long-lived high-affinity bone marrow plasma cells in aged mice. J Immunol 170 (2003) 1267-1273
10. Miller C., and Kelsoe G. Ig VH hypermutation is absent in the germinal centers of aged mice. J Immunol 155 (1995) 3377-3384
11. Rogerson B.J., Harris D.P., Swain S.L., and Burgess D.O. Germinal center B cells in Peyer's patches of aged mice exhibit a normal activation phenotype and highly mutated IgM genes. Mech Ageing Dev 124 (2003) 155-165
12. Yang X., Stedra J., and Cerny J. Relative contribution of T and B cells to hypermutation and selection of the antibody repertoire in germinal centers of aged mice. J Exp Med 183 (1996) 959-970
13. Haynes L., Linton P.J., Eaton S.M., Tonkonogy S.L., and Swain S.L. Interleukin 2, but not other common gamma chain-binding cytokines, can reverse the defect in generation of CD4 effector T cells from naive T cells of aged mice. J Exp Med 190 (1999) 1013-1024
14. Engwerda C.R., Fox B.S., and Handwerger B.S. Cytokine production by T lymphocytes from young and aged mice. J Immunol 156 (1996) 3621-3630
15. Pawelec G., Barnett Y., Forsey R., Frasca D., Globerson A., McLeod J., Caruso C., Franceschi C., Fulop T., Gupta S., et al. T cells and aging, January 2002 update. Front Biosci 7 (2002) d1056-1183
16. Banerjee M., Mehr R., Belelovsky A., Spencer J., and Dunn-Walters D.K. Age- and tissue-specific differences in human germinal center B cell selection revealed by analysis of IgVH gene hypermutation and lineage trees. Eur J Immunol 32 (2002) 1947-1957
17. Gibson K.L., Wu Y.C., Barnett Y., Duggan O., Vaughan R., Kondeatis E., Nilsson B.O., Wikby A., Kipling D., and Dunn-Walters D.K. B-cell diversity decreases in old age and is correlated with poor health status. Aging Cell 8 (2009) 18-25. B cell repertoire as measured by spectratyping and DNA sequencing in individuals aged 86-94 showed less Ig diversity than young especially in the more frail group.
18. Kolar G.R., Mehta D., Wilson P.C., and Capra J.D. Diversity of the Ig repertoire is maintained with age in spite of reduced germinal centre cells in human tonsil lymphoid tissue. Scand J Immunol 64 (2006) 314-324
19. Sherwood E.M., Blomberg B.B., Xu W., Warner C.A., and Riley R.L. Senescent BALB/c mice exhibit decreased expression of lambda5 surrogate light chains and reduced development within the pre-B cell compartment. J Immunol 161 (1998) 4472-4475
20. Miller J.P., and Allman D. The decline in B lymphopoiesis in aged mice reflects loss of very early B-lineage precursors. J Immunol 171 (2003) 2326-2330
21. Alter-Wolf S., Blomberg B.B., and Riley R.L. Deviation of the B cell pathway in senescent mice is associated with reduced surrogate light chain expression and altered immature B cell generation, phenotype, and light chain expression. J Immunol 182 (2009) 138-147
22. Min H., Montecino-Rodriguez E., and Dorshkind K. Effects of aging on the common lymphoid progenitor to pro-B cell transition. J Immunol 176 (2006) 1007-1012
23. Guerrettaz L.M., Johnson S.A., and Cambier J.C. Acquired hematopoietic stem cell defects determine B-cell repertoire changes associated with aging. Proc Natl Acad Sci U S A 105 (2008) 11898-11902
24. Miller J.P., and Cancro M.P. B cells and aging: balancing the homeostatic equation. Exp Gerontol 42 (2007) 396-399. B cells from aged mice survive better in response to BlyS, helping to explain the maintenance of peripheral B cells although being derived from fewer precursors.
25. Johnson S.A., Rozzo S.J., and Cambier J.C. Aging-dependent exclusion of antigen-inexperienced cells from the peripheral B cell repertoire. J Immunol 168 (2002) 5014-5023
26. Weksler M.E. Changes in the B-cell repertoire with age. Vaccine 18 (2000) 1624-1628
27. Franceschi C., Monti D., Sansoni P., and Cossarizza A. The immunology of exceptional individuals: the lesson of centenarians. Immunol Today 16 (1995) 12-16
28. Shi Y., Yamazaki T., Okubo Y., Uehara Y., Sugane K., and Agematsu K. Regulation of aged humoral immune defense against pneumococcal bacteria by IgM memory B cell. J Immunol 175 (2005) 3262-3267
29. Frasca D., Landin A.M., Lechner S.C., Ryan J.G., Schwartz R., Riley R.L., and Blomberg B.B. Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells. J Immunol 180 (2008) 5283-5290. Aged human B cells have less total B cells, less class switch memory B cells, and show less E47, AID, and CSR when stimulated in vitro with anti-CD40 plus IL-4.
30. Colonna-Romano G., Bulati M., Aquino A., Scialabba G., Candore G., Lio D., Motta M., Malaguarnera M., and Caruso C. B cells in the aged: CD27, CD5, and CD40 expression. Mech Ageing Dev 124 (2003) 389-393
31. Siegrist C.A., and Aspinall R. B-cell responses to vaccination at the extremes of age. Nat Rev Immunol 9 (2009) 185-194
32. McKenna R.W., Washington L.T., Aquino D.B., Picker L.J., and Kroft S.H. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry. Blood 98 (2001) 2498-2507
33. Rossi M.I., Yokota T., Medina K.L., Garrett K.P., Comp P.C., Schipul Jr. A.H., and Kincade P.W. B lymphopoiesis is active throughout human life, but there are developmental age-related changes. Blood 101 (2003) 576-584
34. Frasca D., Riley R.L., and Blomberg B.B. Aging murine B cells have decreased class switch induced by anti-CD40 or BAFF. Exp Gerontol 42 (2007) 192-203
35. Good K.L., Avery D.T., and Tangye S.G. Resting human memory B cells are intrinsically programmed for enhanced survival and responsiveness to diverse stimuli compared to naive B cells. J Immunol 182 (2009) 890-901. Human B cell subsets analyzed by microarray show different phenotypes for activation, costimulation, and survival markers.
36. Nicoletti C., Yang X., and Cerny J. Repertoire diversity of antibody response to bacterial antigens in aged mice. III. Phosphorylcholine antibody from young and aged mice differ in structure and protective activity against infection with Streptococcus pneumoniae. J Immunol 150 (1993) 543-549
37. Nicoletti C., Borghesi-Nicoletti C., Yang X.H., Schulze D.H., and Cerny J. Repertoire diversity of antibody response to bacterial antigens in aged mice. II. Phosphorylcholine-antibody in young and aged mice differ in both VH/VL gene repertoire and in specificity. J Immunol 147 (1991) 2750-2755
38. Yang X., Stedra J., and Cerny J. Repertoire diversity of antibody response to bacterial antigens in aged mice. IV. Study of VH and VL gene utilization in splenic antibody foci by in situ hybridisation. J Immunol 152 (1994) 2214-2221
39. Ben-Yehuda A., Szabo P., LeMaoult J., Manavalan J.S., and Weksler M.E. Increased VH 11 and VH Q52 gene use by splenic B cells in old mice associated with oligoclonal expansions of CD5+ B cells. Mech Ageing Dev 103 (1998) 111-121
40. Goidl E.A., Innes J.B., and Weksler M.E. Immunological studies of aging. II. Loss of IgG and high avidity plaque-forming cells and increased suppressor cell activity in aging mice. J Exp Med 144 (1976) 1037-1048
41. Smith A.M. The effects of age on the immune response to type III pneumococcal polysaccharide (SIII) and bacterial lipopolysaccharide (LPS) in BALB/c, SJL/J, and C3H mice. J Immunol 116 (1976) 469-474
42. Speziali E., Santiago A.F., Fernandes R.M., Vaz N.M., Menezes J.S., and Faria A.M. Specific immune responses but not basal functions of B and T cells are impaired in aged mice. Cell Immunol 256 (2009) 1-5
43. Paganelli R., Quinti I., Fagiolo U., Cossarizza A., Ortolani C., Guerra E., Sansoni P., Pucillo L.P., Scala E., Cozzi E., et al. Changes in circulating B cells and immunoglobulin classes and subclasses in a healthy aged population. Clin Exp Immunol 90 (1992) 351-354
44. Muramatsu M., Nagaoka H., Shinkura R., Begum N.A., and Honjo T. Discovery of activation-induced cytidine deaminase, the engraver of antibody memory. Adv Immunol 94 (2007) 1-36
45. Nussenzweig M.C., and Alt F.W. Antibody diversity: one enzyme to rule them all. Nat Med 10 (2004) 1304-1305
46. Rada C., Williams G.T., Nilsen H., Barnes D.E., Lindahl T., and Neuberger M.S. Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr Biol 12 (2002) 1748-1755
47. Quong M.W., Romanow W.J., and Murre C. E protein function in lymphocyte development. Annu Rev Immunol 20 (2002) 301-322
48. Sayegh C.E., Quong M.W., Agata Y., and Murre C. E-proteins directly regulate expression of activation-induced deaminase in mature B cells. Nat Immunol 4 (2003) 586-593
49. Frasca D., Van der Put E., Riley R.L., and Blomberg B.B. Reduced Ig class switch in aged mice correlates with decreased E47 and activation-induced cytidine deaminase. J Immunol 172 (2004) 2155-2162
50. Han S., Marinova E., and Zheng B. Rectification of age-related impairment in Ig gene hypermutation during a memory response. Int Immunol 16 (2004) 525-532
51. Frasca D., Van der Put E., Landin A.M., Gong D., Riley R.L., and Blomberg B.B. RNA stability of the E2A-encoded transcription factor E47 is lower in splenic activated B cells from aged mice. J Immunol 175 (2005) 6633-6644
52. Van der Put E., Frasca D., King A.M., Blomberg B.B., and Riley R.L. Decreased E47 in senescent B cell precursors is stage specific and regulated posttranslationally by protein turnover. J Immunol 173 (2004) 818-827
53. Stoecklin G., and Anderson P. Posttranscriptional mechanisms regulating the inflammatory response. Adv Immunol 89 (2006) 1-37. This review discusses the factors that regulate the stability of the mRNAs for proinflammatory cytokines especially TNF.
54. Frasca D., Landin A.M., Alvarez J.P., Blackshear P.J., Riley R.L., and Blomberg B.B. Tristetraprolin, a negative regulator of mRNA stability, is increased in old B cells and is involved in the degradation of E47 mRNA. J Immunol 179 (2007) 918-927. This paper describes for the first time that the mRNA for E47 is a target for the degradation protein TTP.
55. Dorsett Y., McBride K.M., Jankovic M., Gazumyan A., Thai T.H., Robbiani D.F., Di Virgilio M., San-Martin B.R., Heidkamp G., Schwickert T.A., et al. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity 28 (2008) 630-638. The authors show that increased levels of AID result in a small increase of CSR but no effect on SHM, although Myc oncogene-IgH translocation is increased by AID.
56. Teng G., Hakimpour P., Landgraf P., Rice A., Tuschl T., Casellas R., and Papavasiliou F.N. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 28 (2008) 521-529. This paper demonstrates that miR-155 is upregulated in murine B cells undergoing CSR and it targets AID degradation. These and the previous authors [55] showed that disruption of the miR-155 target site in the AID 3′-UTR increased AID and CSR but SHM was unchanged.